• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.58% Nasdaq Up 0.47%

    Alnylam Pharmaceuticals, Inc. (ALNY)

    -NasdaqGS
    46.86 Down 1.42(2.94%) 4:00PM EST
    |After Hours : 46.00 Down 0.86 (1.84%) 5:12PM EST - Nasdaq Real Time Price
    Prev Close:48.28
    Open:48.59
    Bid:45.50 x 100
    Ask:46.86 x 200
    1y Target Est:62.73
    Beta:3.16165
    Earnings Date:May 1 - May 5 (Est.)
    Day's Range:46.37 - 48.59
    52wk Range:31.38 - 80.11
    Volume:728,230
    Avg Vol (3m):1,147,640
    Market Cap:4.03B
    P/E (ttm):N/A
    EPS (ttm):-4.79
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALNY

    Comparison

    Symbol% ChgMkt Cap
    ALNYDown 2.94%4.03B
    PFE 0.00%204.02B
    MRKUp 0.14%180.54B
    1 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):88.06
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-17) :-5.09
    Quarterly EPS Est (Mar-17) :-1.28
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-0.21

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference. Its pipeline of investigational RNAi therapeutics is focused on genetic medicines, cardio-metabolic d... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback